MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ONDRUSEK, M. G.
Right arrow Articles by LESLIE, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ONDRUSEK, M. G.
Right arrow Articles by LESLIE, S. W.

Molecular Pharmacology, Vol 15, 386-395, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Effects of Acute and Chronic Barbiturate Administration on Synaptosomal Calcium Accumulation

MICHAEL G. ONDRUSEK 1, JOHN K. BELKNAP 1, and STEVEN W. LESLIE 2

1 Department of Psychology, College of Pharmacy, the University of Texas at Austin, Austin, Texas 78712
2 Department of Pharmacology, College of Pharmacy, the University of Texas at Austin, Austin, Texas 78712

Synaptosomes were isolated from four treatment groups of DBA/2J mice: Group I-Control; Group II-7 day tolerant (received dietary phenobarbital, 2.5 mg/g Purina Lab Chow for 7 days); Group III-20 hr withdrawn; and Group IV-7 day recovered (received dietary phenobarbital for 7 days followed by normal diet for 7 days). Pentobarbital (0.45 mM) added in vitro to synaptosomes from control mice significantly depressed (21.4%) potassium depolarized 45Ca++ accumulation but did not significantly alter nondepolarized 45Ca++ uptake or subsequent 45Ca++ efflux. Chronic administration of phenobarbital to mice in the tolerant and withdrawn conditions resulted in behavioral tolerance and subsequent withdrawal symptomatology, but neither KCl-induced 45Ca++ accumulation nor 45Ca++ efflux was significantly altered. In vitro addition of pentobarbital (0.45 mM) to synaptosomes from tolerant mice did not significantly depress KCl-induced 45Ca++ accumulation (8.1%) but did significantly depress KCl-induced 45Ca++ accumulation by synaptosomes from withdrawn mice (15.2%) and recovered mice (16.8%). These data suggest that barbiturates may depress calcium-mediated stimulus-secretion coupling events contributing to central nervous system depression. Further, functional tolerance after chronic barbiturate treatment may result from a membrane adaptation facilitating calcium-mediated secretory functions.

Submitted on November 21, 1977
Accepted on October 10, 1978







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics